Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen - 42 Year Stock Price History | AMGN

Historical daily share price chart and data for Amgen since 1983 adjusted for splits and dividends. The latest closing stock price for Amgen as of July 11, 2025 is 295.27.
  • The all-time high Amgen stock closing price was 329.11 on September 20, 2024.
  • The Amgen 52-week high stock price is 346.85, which is 17.5% above the current share price.
  • The Amgen 52-week low stock price is 253.30, which is 14.2% below the current share price.
  • The average Amgen stock price for the last 52 weeks is 300.11.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amgen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 287.3154 254.9490 324.4920 254.2700 295.2700 15.21%
2024 293.2592 283.8460 329.1120 252.7440 256.2860 -6.77%
2023 234.7975 241.3680 275.3230 201.2850 274.9020 13.46%
2022 224.0643 202.7150 267.8800 197.7610 242.2810 20.43%
2021 203.6112 196.5840 226.4500 177.8460 201.1770 0.89%
2020 198.0202 202.6400 223.3020 154.8990 199.4120 -1.99%
2019 162.9521 157.1800 205.2560 138.3380 203.4590 27.60%
2018 151.9959 140.8370 170.5720 133.1230 159.4490 15.23%
2017 134.0879 116.6690 150.9450 116.6690 138.3710 22.27%
2016 119.2815 119.4240 135.0370 103.9730 113.1700 -7.57%
2015 118.1398 118.2250 131.9110 99.2415 122.4340 3.95%
2014 96.1089 83.9977 126.9130 80.7659 117.7810 42.33%
2013 74.7865 63.4899 85.7366 58.4548 82.7501 34.80%
2012 53.9376 44.7942 64.2163 44.5497 61.3890 36.83%
2011 38.8587 38.4141 45.2344 33.3798 44.8641 18.17%
2010 38.5533 39.9147 42.2797 34.8251 37.9646 -2.95%
2009 37.9750 40.7930 44.5410 31.1946 39.1195 -2.04%
2008 35.3652 32.2250 45.5645 27.6402 39.9355 24.35%
2007 40.0561 47.3002 52.4520 32.1143 32.1143 -32.02%
2006 48.8514 55.5708 55.5708 44.2022 47.2380 -13.38%
2005 48.3713 44.4511 59.5886 39.5551 54.5335 22.93%
2004 40.7310 43.1165 45.7996 36.4433 44.3612 3.82%
2003 42.4907 34.1059 49.4716 33.8017 42.7292 27.82%
2002 34.1556 39.0019 43.2064 21.4856 33.4282 -14.35%
2001 43.0917 43.4795 51.3024 35.6204 39.0296 -11.73%
2000 45.2732 43.5227 53.9388 35.4838 44.2143 6.45%
1999 25.6592 18.5631 44.8626 18.0877 41.5346 129.77%
1998 11.5528 9.3248 18.1309 8.1470 18.0768 93.19%
1997 9.6340 9.4436 11.8208 7.9417 9.3572 -0.46%
1996 10.1152 10.0703 11.3237 8.9034 9.4004 -8.42%
1995 7.0466 5.0352 10.2648 4.8839 10.2648 101.27%
1994 4.1853 4.2464 5.1324 3.0565 5.1000 19.19%
1993 3.6349 6.1048 6.1157 2.7229 4.2788 -29.91%
1992 5.5746 6.4615 6.7208 4.3220 6.1048 -6.77%
1991 3.9052 1.8369 6.5479 1.6640 6.5479 265.05%
1990 1.1382 0.7419 1.8260 0.6447 1.7937 154.10%
1989 0.6318 0.4610 0.8644 0.4592 0.7059 45.19%
1988 0.4406 0.4646 0.5150 0.3710 0.4862 8.87%
1987 0.4645 0.3404 0.6411 0.2341 0.4466 40.93%
1986 0.2914 0.1819 0.4088 0.1801 0.3169 62.93%
1985 0.1105 0.0685 0.2089 0.0667 0.1945 169.76%
1984 0.0791 0.1044 0.1189 0.0522 0.0721 -30.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $158.768B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $220.597B 16.47
Gilead Sciences (GILD) United States $136.384B 14.17
Vertex Pharmaceuticals (VRTX) United States $120.399B 0.00
Bristol Myers Squibb (BMY) United States $95.364B 6.38
GSK (GSK) United Kingdom $78.372B 9.38
CSL (CSLLY) Australia $76.612B 0.00
Regeneron Pharmaceuticals (REGN) United States $61.296B 14.88
Alnylam Pharmaceuticals (ALNY) United States $41.064B 0.00
Argenex SE (ARGX) Netherlands $34.208B 93.37
BioNTech SE (BNTX) Germany $27.138B 0.00
Royalty Pharma (RPRX) United States $20.151B 8.51
Biogen (BIIB) United States $19.666B 8.48
Insmed (INSM) United States $18.626B 0.00
Illumina (ILMN) United States $15.711B 29.80
Genmab (GNMSF) Denmark $14.203B 14.52
Genmab (GMAB) Denmark $13.729B 15.40
Incyte (INCY) United States $13.277B 100.87
Moderna (MRNA) United States $13.010B 0.00
Exelixis (EXEL) United States $12.234B 20.77
BioMarin Pharmaceutical (BMRN) United States $11.142B 18.10
QIAGEN (QGEN) Netherlands $10.699B 20.82
Ascendis Pharma (ASND) Denmark $10.696B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $9.792B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.924B 0.00
Bio-Techne Corp (TECH) United States $8.487B 31.66
Blueprint Medicines (BPMC) United States $8.350B 0.00
Roivant Sciences (ROIV) United Kingdom $7.723B 0.00
Repligen (RGEN) United States $7.314B 81.88
Legend Biotech (LEGN) United States $7.159B 0.00
Anbio Biotechnology (NNNN) Germany $7.088B 0.00
Revolution Medicines (RVMD) United States $7.082B 0.00
Halozyme Therapeutics (HALO) United States $7.042B 13.48
Bio-Rad Laboratories (BIO.B) United States $7.014B 24.41
Jazz Pharmaceuticals (JAZZ) Ireland $6.673B 6.55
Guardant Health (GH) United States $6.225B 0.00
TG Therapeutics (TGTX) United States $5.887B 154.52
Nuvalent (NUVL) United States $5.812B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.516B 0.00
Telix Pharmaceuticals (TLX) Australia $5.404B 0.00
Axsome Therapeutics (AXSM) United States $5.366B 0.00
Alkermes (ALKS) Ireland $4.993B 13.40
CRISPR Therapeutics AG (CRSP) Switzerland $4.905B 0.00
Vaxcyte (PCVX) United States $4.635B 0.00
Cytokinetics (CYTK) United States $4.420B 0.00
ADMA Biologics Inc (ADMA) United States $4.419B 33.05
Krystal Biotech (KRYS) United States $4.282B 33.00
Metsera (MTSR) United States $4.127B 0.00
Akero Therapeutics (AKRO) United States $4.111B 0.00
Zealand Pharma (ZLDPF) Denmark $4.088B 0.00
PTC Therapeutics (PTCT) United States $3.848B 6.70
Arcellx (ACLX) United States $3.801B 0.00
Avidity Biosciences (RNA) United States $3.790B 0.00
Merus (MRUS) Netherlands $3.772B 0.00
Zai Lab (ZLAB) China $3.636B 0.00
Scholar Rock Holding (SRRK) United States $3.555B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.511B 30.85
Viking Therapeutics (VKTX) United States $3.494B 0.00
Ascentage Pharma Group - (AAPG) China $3.331B 0.00
Protagonist Therapeutics (PTGX) United States $3.285B 70.67
MoonLake Immunotherapeutics (MLTX) Switzerland $3.137B 0.00
Immunovant (IMVT) United States $3.101B 0.00
Kymera Therapeutics (KYMR) United States $2.897B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.796B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.790B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.609B 0.00
Alvotech (ALVO) Luxembourg $2.569B 14.69
Arrowhead Pharmaceuticals (ARWR) United States $2.529B 0.00
ImmunityBio (IBRX) United States $2.480B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.472B 0.00
Apellis Pharmaceuticals (APLS) United States $2.443B 0.00
Ligand Pharmaceuticals (LGND) United States $2.348B 0.00
Twist Bioscience (TWST) United States $2.279B 0.00
Agios Pharmaceuticals (AGIO) United States $2.262B 0.00
Bavarian Nordic (BVNRY) Denmark $2.236B 11.81
Recursion Pharmaceuticals (RXRX) United States $2.146B 0.00
Beam Therapeutics (BEAM) United States $2.128B 0.00
Denali Therapeutics (DNLI) United States $2.109B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.050B 0.00
CG Oncology (CGON) United States $2.037B 0.00
Belite Bio (BLTE) United States $2.013B 0.00
Vericel (VCEL) United States $2.010B 1331.00
Disc Medicine (IRON) United States $1.971B 0.00
IDEAYA Biosciences (IDYA) United States $1.969B 0.00
NovoCure (NVCR) Jersey $1.962B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.952B 12.98
Amicus Therapeutics (FOLD) United States $1.875B 203.00
Certara (CERT) United States $1.799B 33.61
Adaptive Biotechnologies (ADPT) United States $1.796B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.789B 0.00
Sarepta Therapeutics (SRPT) United States $1.786B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.759B 0.00
Apogee Therapeutics (APGE) United States $1.756B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.646B 0.00
89BIO (ETNB) United States $1.606B 0.00
Celldex Therapeutics (CLDX) United States $1.521B 0.00
Vera Therapeutics (VERA) United States $1.519B 0.00
Janux Therapeutics (JANX) United States $1.488B 0.00
GRAIL (GRAL) United States $1.465B 0.00
Travere Therapeutics (TVTX) United States $1.463B 0.00
Edgewise Therapeutics (EWTX) United States $1.456B 0.00
Biohaven (BHVN) United States $1.422B 0.00
Mesoblast (MESO) Australia $1.420B 0.00
ANI Pharmaceuticals (ANIP) United States $1.407B 14.50
Viridian Therapeutics (VRDN) United States $1.390B 0.00
Pharvaris (PHVS) Netherlands $1.314B 0.00
Dynavax Technologies (DVAX) United States $1.270B 75.57
Cogent Biosciences (COGT) United States $1.250B 0.00
CureVac (CVAC) Germany $1.225B 5.93
Liquidia Technologies (LQDA) United States $1.204B 0.00
WAVE Life Sciences (WVE) Singapore $1.198B 0.00
AbCellera Biologics (ABCL) Canada $1.197B 0.00
Intellia Therapeutics (NTLA) United States $1.195B 0.00
MannKind (MNKD) United States $1.146B 23.56
Novavax (NVAX) United States $1.108B 2.58
Structure Therapeutics (GPCR) United States $1.090B 0.00
Pacira BioSciences (PCRX) United States $1.060B 10.09
Praxis Precision Medicines (PRAX) United States $1.029B 0.00
Cidara Therapeutics (CDTX) United States $1.019B 0.00
Arcus Biosciences (RCUS) United States $0.988B 0.00
MiMedx (MDXG) United States $0.984B 23.79
LENZ Therapeutics (LENZ) United States $0.976B 0.00
Nurix Therapeutics (NRIX) United States $0.951B 0.00
Anavex Life Sciences (AVXL) United States $0.948B 0.00
Oric Pharmaceuticals (ORIC) United States $0.946B 0.00
Spyre Therapeutics (SYRE) United States $0.946B 0.00
Mineralys Therapeutics (MLYS) United States $0.944B 0.00
Sana Biotechnology (SANA) United States $0.942B 0.00
NeoGenomics (NEO) United States $0.934B 0.00
Zymeworks (ZYME) United States $0.930B 0.00
BGM Group (BGM) China $0.905B 0.00
Sionna Therapeutics (SION) United States $0.901B 0.00
Niagen Bioscience (NAGE) United States $0.890B 125.56
Replimune (REPL) United States $0.846B 0.00
Geron (GERN) United States $0.841B 0.00
GH Research (GHRS) Ireland $0.826B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.825B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
UniQure (QURE) Netherlands $0.789B 0.00
Oculis Holding AG (OCS) Switzerland $0.789B 0.00
Vir Biotechnology (VIR) United States $0.781B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
AnaptysBio (ANAB) United States $0.770B 0.00
Trevi Therapeutics (TRVI) United States $0.768B 0.00
Jyong Biotech (MENS) Taiwan $0.761B 0.00
CorMedix Inc (CRMD) United States $0.761B 51.00
Immunome (IMNM) United States $0.752B 0.00
Nuvation Bio (NUVB) United States $0.749B 0.00
ArriVent BioPharma (AVBP) United States $0.740B 0.00
Immatics (IMTX) Germany $0.726B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.713B 0.00
Gyre Therapeutics (GYRE) United States $0.702B 187.25
Day One Biopharmaceuticals (DAWN) United States $0.688B 0.00
MeiraGTx Holdings (MGTX) United States $0.681B 0.00
Pharming Group (PHAR) Netherlands $0.680B 0.00
Maze Therapeutics (MAZE) United States $0.659B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.657B 0.00
Urogen Pharma (URGN) United States $0.657B 0.00
Stoke Therapeutics (STOK) United States $0.648B 15.01
Dianthus Therapeutics (DNTH) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Tango Therapeutics (TNGX) United States $0.643B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.641B 0.00
Iovance Biotherapeutics (IOVA) United States $0.624B 0.00
Upstream Bio (UPB) United States $0.618B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.609B 0.00
Arbutus Biopharma (ABUS) United States $0.607B 0.00
Keros Therapeutics (KROS) United States $0.586B 0.00
Prime Medicine (PRME) United States $0.585B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.584B 0.00
Sage Therapeutics (SAGE) United States $0.581B 0.00
Arvinas (ARVN) United States $0.569B 0.00
Castle Biosciences (CSTL) United States $0.568B 38.55
Bicycle Therapeutics (BCYC) United Kingdom $0.554B 0.00
Tyra Biosciences (TYRA) United States $0.545B 0.00
Kura Oncology (KURA) United States $0.544B 0.00
Precigen (PGEN) United States $0.540B 0.00
Rapport Therapeutics (RAPP) United States $0.533B 0.00
Bicara Therapeutics (BCAX) United States $0.530B 0.00
Opthea (OPT) Australia $0.525B 0.00
Abivax SA (ABVX) France $0.525B 0.00
Septerna (SEPN) United States $0.523B 0.00
Celcuity (CELC) United States $0.516B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.505B 0.00
Myriad Genetics (MYGN) United States $0.492B 0.00
ATyr Pharma (ATYR) United States $0.472B 0.00
Zenas BioPharma (ZBIO) United States $0.468B 0.00
Fortrea Holdings (FTRE) United States $0.462B 12.78
Cullinan Therapeutics (CGEM) United States $0.454B 0.00
Rezolute (RZLT) United States $0.450B 0.00
Kamada (KMDA) Israel $0.446B 26.72
Cytek Biosciences (CTKB) United States $0.437B 0.00
MBX Biosciences (MBX) United States $0.436B 0.00
REGENXBIO (RGNX) United States $0.435B 0.00
Terns Pharmaceuticals (TERN) United States $0.428B 0.00
PureTech Health (PRTC) United States $0.428B 0.00
Fulcrum Therapeutics (FULC) United States $0.423B 0.00
Tectonic Therapeutic (TECX) United States $0.423B 0.00
Erasca (ERAS) United States $0.411B 0.00
Solid Biosciences (SLDB) United States $0.408B 0.00
Emergent Biosolutions (EBS) United States $0.399B 0.00
ITeos Therapeutics (ITOS) United States $0.394B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.390B 0.00
Eton Pharmaceuticals (ETON) United States $0.389B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.374B 0.00
Compass Therapeutics (CMPX) United States $0.373B 0.00
Astria Therapeutics (ATXS) United States $0.359B 0.00
Humacyte (HUMA) United States $0.358B 0.00
Amarin (AMRN) Ireland $0.351B 0.00
Cartesian Therapeutics (RNAC) United States $0.346B 0.00
Prothena (PRTA) Ireland $0.344B 0.00
Absci (ABSI) United States $0.341B 0.00
Benitec Biopharma (BNTC) United States $0.335B 0.00
Ocugen (OCGN) United States $0.333B 0.00
Northwest Biotherapeutics (NWBO) United States $0.332B 0.00
XOMA Royalty (XOMA) United States $0.325B 0.00
Aura Biosciences (AURA) United States $0.322B 0.00
Inventiva S.A (IVA) France $0.320B 0.00
Olema Pharmaceuticals (OLMA) United States $0.318B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.317B 64.50
Rocket Pharmaceuticals (RCKT) United States $0.316B 0.00
Inhibrx Biosciences (INBX) United States $0.315B 0.19
Atea Pharmaceuticals (AVIR) United States $0.314B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.312B 0.00
Vor Biopharma (VOR) $0.312B 0.00
Gossamer Bio (GOSS) United States $0.309B 0.00
Lifecore Biomedical (LFCR) United States $0.307B 0.00
Neurogene (NGNE) United States $0.306B 0.00
Foghorn Therapeutics (FHTX) United States $0.301B 0.00
DBV Technologies S.A (DBVT) France $0.296B 0.00
Abeona Therapeutics (ABEO) United States $0.294B 0.00
Palvella Therapeutics (PVLA) United States $0.293B 0.00
Candel Therapeutics (CADL) United States $0.291B 0.00
Sagimet Biosciences (SGMT) United States $0.290B 0.00
Annexon (ANNX) United States $0.283B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.282B 0.00
Allogene Therapeutics (ALLO) United States $0.280B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.279B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.278B 0.00
Cardiff Oncology (CRDF) United States $0.271B 0.00
Aardvark Therapeutics (AARD) United States $0.264B 0.00
Verastem (VSTM) United States $0.257B 0.00
Alpha Teknova (TKNO) United States $0.257B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.256B 0.00
Tvardi Therapeutics (TVRD) United States $0.256B 0.00
MiNK Therapeutics (INKT) United States $0.256B 0.00
Crescent Biopharma (CBIO) United States $0.253B 0.00
Entrada Therapeutics (TRDA) United States $0.249B 8.09
Codexis (CDXS) United States $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.244B 0.00
Adherex Technologies (FENC) United States $0.242B 0.00
Editas Medicine (EDIT) United States $0.241B 0.00
Prima BioMed (IMMP) Australia $0.241B 0.00
Kodiak Sciences (KOD) United States $0.239B 0.00
MaxCyte (MXCT) United States $0.236B 0.00
ScPharmaceuticals (SCPH) United States $0.231B 0.00
Monopar Therapeutics (MNPR) United States $0.225B 0.00
Design Therapeutics (DSGN) United States $0.223B 0.00
Semper Paratus Acquisition (TVGN) United States $0.219B 0.00
Adocia (ADOCY) France $0.216B 0.00
CARGO Therapeutics (CRGX) United States $0.212B 0.00
BioStem Technologies (BSEM) $0.210B 8.52
Neumora Therapeutics (NMRA) United States $0.209B 0.00
AC Immune (ACIU) Switzerland $0.205B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.205B 0.00
Citius Oncology (CTOR) United States $0.202B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.197B 0.00
CytomX Therapeutics (CTMX) United States $0.195B 5.04
Ventyx Biosciences (VTYX) United States $0.195B 0.00
Agenus (AGEN) United States $0.194B 0.00
Voyager Therapeutics (VYGR) United States $0.193B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.193B 0.00
Alumis (ALMS) United States $0.192B 0.00
SELLAS Life Sciences (SLS) United States $0.184B 0.00
GENFIT S.A (GNFT) France $0.183B 0.00
Bright Minds Biosciences (DRUG) United States $0.175B 0.00
Kyverna Therapeutics (KYTX) United States $0.174B 0.00
I-Mab (IMAB) United States $0.174B 0.00
Alpha Cognition (ACOG) Canada $0.173B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.173B 0.00
EnGene Holdings (ENGN) Canada $0.169B 0.00
Puma Biotechnology (PBYI) United States $0.168B 4.40
Nuvectis Pharma (NVCT) United States $0.165B 0.00
BioAge Labs (BIOA) United States $0.163B 0.00
Black Diamond Therapeutics (BDTX) United States $0.163B 47.83
Anika Therapeutics (ANIK) United States $0.162B 0.00
Alector (ALEC) United States $0.161B 0.00
Innate Pharma S.A (IPHA) France $0.161B 0.00
Instil Bio (TIL) United States $0.161B 0.00
Immuneering (IMRX) United States $0.159B 0.00
C4 Therapeutics (CCCC) United States $0.158B 0.00
Spero Therapeutics (SPRO) United States $0.157B 0.00
DiaMedica Therapeutics (DMAC) United States $0.156B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.153B 0.00
Caribou Biosciences (CRBU) United States $0.152B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
Greenwich LifeSciences (GLSI) United States $0.145B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
Compugen (CGEN) Israel $0.142B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.140B 0.00
Rapt Therapeutics (RAPT) United States $0.140B 0.00
23andMe Holding (MEHCQ) United States $0.136B 0.00
Fate Therapeutics (FATE) United States $0.132B 0.00
Nkarta (NKTX) United States $0.130B 0.00
Genelux (GNLX) United States $0.129B 0.00
Elicio Therapeutics (ELTX) United States $0.129B 0.00
Seer (SEER) United States $0.124B 0.00
Skye Bioscience (SKYE) United States $0.123B 0.00
Actuate Therapeutics (ACTU) United States $0.120B 0.00
BioHarvest Sciences (BHST) Canada $0.118B 0.00
Sangamo Therapeutics (SGMO) United States $0.115B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.112B 0.00
Oncolytics Biotech (ONCY) Canada $0.111B 0.00
Tenaya Therapeutics (TNYA) United States $0.111B 0.00
Seres Therapeutics (MCRB) United States $0.110B 0.00
HilleVax (HLVX) United States $0.105B 0.00
Coya Therapeutics (COYA) United States $0.103B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
Coherus Oncology (CHRS) United States $0.102B 0.00
Contineum Therapeutics (CTNM) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
TuHURA Biosciences (HURA) United States $0.100B 0.00
Nautilus Biotechnology (NAUT) United States $0.099B 0.00
Elutia (ELUT) United States $0.098B 0.00
IO Biotech (IOBT) Denmark $0.097B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.096B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.096B 0.00
OKYO Pharma (OKYO) $0.095B 0.00
BeyondSpring (BYSI) United States $0.093B 0.00
Climb Bio (CLYM) United States $0.093B 0.00
Adagene (ADAG) China $0.090B 0.00
Whitehawk Therapeutics (WHWK) United States $0.090B 0.00
Zura Bio (ZURA) United States $0.090B 0.00
Invivyd (IVVD) United States $0.089B 0.00
Cellectis S.A (CLLS) France $0.088B 0.00
Cabaletta Bio (CABA) United States $0.088B 0.00
Pliant Therapeutics (PLRX) United States $0.087B 0.00
XBiotech (XBIT) United States $0.086B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.085B 0.00
Connect Biopharma Holdings (CNTB) United States $0.084B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.083B 0.00
Quince Therapeutics (QNCX) United States $0.083B 0.00
EXoZymes (EXOZ) United States $0.082B 0.00
IGM Biosciences (IGMS) United States $0.081B 0.00
Immunic (IMUX) United States $0.080B 0.00
TELA Bio (TELA) United States $0.079B 0.00
Entera Bio (ENTX) Israel $0.079B 0.00
Biomea Fusion (BMEA) United States $0.075B 0.00
Immix Biopharma (IMMX) United States $0.074B 0.00
Genenta Science S.p.A (GNTA) Italy $0.072B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.071B 0.00
Alto Neuroscience (ANRO) United States $0.070B 0.00
Oncobiologics (OTLK) United States $0.069B 0.00
Forte Biosciences (FBRX) United States $0.069B 0.00
VistaGen Therapeutics (VTGN) United States $0.069B 0.00
Clearside Biomedical (CLSD) United States $0.069B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.068B 0.00
ABVC BioPharma (ABVC) United States $0.067B 0.00
Opus Genetics (IRD) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.067B 0.00
Repare Therapeutics (RPTX) Canada $0.064B 0.00
Sutro Biopharma (STRO) United States $0.064B 0.00
MediciNova (MNOV) United States $0.062B 0.00
CervoMed (CRVO) United States $0.062B 0.00
Adicet Bio (ACET) United States $0.062B 0.00
Adlai Nortye (ANL) Cayman Islands $0.059B 0.00
InflaRx (IFRX) Germany $0.059B 0.00
Earth Science Tech (ETST) United States $0.059B 0.00
Applied Therapeutics (APLT) United States $0.059B 0.00
Cue Biopharma (CUE) United States $0.058B 0.00
PDS Biotechnology (PDSB) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Senti Biosciences (SNTI) United States $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
INmune Bio (INMB) United States $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.054B 0.00
Quantum Biopharma (QNTM) Canada $0.054B 0.00
Werewolf Therapeutics (HOWL) United States $0.053B 0.00
Adverum Biotechnologies (ADVM) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.053B 0.00
Jasper Therapeutics (JSPR) United States $0.053B 0.00
ZIVO Bioscience (ZIVO) United States $0.051B 0.00
Aligos Therapeutics (ALGS) United States $0.051B 0.00
Celularity (CELU) United States $0.051B 0.00
Inovio Pharmaceuticals (INO) United States $0.050B 0.00
Artiva Biotherapeutics (ARTV) United States $0.050B 0.00
Precision BioSciences (DTIL) United States $0.049B 0.00
Grace Therapeutics (GRCE) Canada $0.048B 0.00
RenovoRx (RNXT) United States $0.047B 0.00
Renovaro (RENB) United States $0.046B 0.00
Exicure (XCUR) United States $0.046B 0.00
Kalaris Therapeutics (KLRS) United States $0.045B 0.00
Scilex Holding (SCLX) United States $0.045B 0.00
Mersana Therapeutics (MRSN) United States $0.043B 0.00
Pluri (PLUR) Israel $0.042B 0.00
PepGen (PEPG) United States $0.041B 0.00
Medicus Pharma (MDCX) United States $0.041B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Lantern Pharma (LTRN) United States $0.040B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
Hyperion DeFi (HYPD) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.038B 0.00
KALA BIO (KALA) United States $0.038B 0.00
Rani Therapeutics Holdings (RANI) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.036B 0.00
Cognition Therapeutics (CGTX) United States $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.033B 0.00
Q32 Bio (QTTB) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
CAMP4 Therapeutics (CAMP) United States $0.030B 0.00
Femasys (FEMY) United States $0.030B 0.00
Dyadic (DYAI) United States $0.030B 0.00
Clene (CLNN) United States $0.030B 0.00
Ovid Therapeutics (OVID) United States $0.029B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.028B 0.00
CalciMedica (CALC) United States $0.028B 0.00
Boundless Bio (BOLD) United States $0.027B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
ALX Oncology Holdings (ALXO) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Passage Bio (PASG) United States $0.025B 0.00
FibroBiologics (FBLG) United States $0.025B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.022B 0.00
Longeveron (LGVN) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Curis (CRIS) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Cingulate (CING) United States $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Athira Pharma (ATHA) United States $0.017B 0.00
Rallybio (RLYB) United States $0.017B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Advanced Biomed (ADVB) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Beyond Air (XAIR) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
MetaVia (MTVA) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
IBio (IBIO) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Artelo Biosciences (ARTL) United States $0.013B 0.00
Promis Neurosciences (PMN) Canada $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Equillium (EQ) United States $0.013B 0.00
Synaptogenix (TAOX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Cyclerion Therapeutics (CYCN) United States $0.012B 0.00
Mustang Bio (MBIO) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
NextCure (NXTC) United States $0.011B 0.00
Novogen (KZIA) Australia $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
X4 Pharmaceuticals (XFOR) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Evogene (EVGN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.006B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
LakeShore Biopharma (LSB) China $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00